NBIX: Neurocrine Biosciences, Inc. Company Short-Term Debt
Neurocrine Biosciences (NBIX) operates in a highly competitive environment against industry behemoths and startups. This chart of the company's current liabilities illustrates borrowing trends, where the 0.02 metric reflects the most recent value. To accelerate drug development, the business is implementing molecular modeling systems. The process is being optimized through the deployment of robotic complexes for high-throughput bioscreening.
Summary analytical data breakdowns for Neurocrine Corp (NBIX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Neurocrine Biosciences|NBIX - Long-Term Debt to Capital|Short-Term Debt to Equity Neurocrine Biosciences|NBIX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Neurocrine Biosciences, Inc.|NBIX - Long-Term Debt|Company Short-Term Debts Neurocrine Biosciences|Quick Liquidity neurocrine.com
- earnings and multiples data:
General company analysis:NBIX - Neurocrine Biosciences, Inc.
Liquidity control is critically important for Neurocrine Biosciences (NBIX) during its structural growth phase. This metric aggregates all obligations with a maturity of up to one year, reflecting the current pressure on cash flows. By analyzing short-term borrowed resources, an investor assesses the company's ability to service debt without compromising R&D. The stability of this indicator confirms that revenues from core drugs effectively cover operational loans, ensuring financial resilience while scaling clinical trials.
Main competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Short-Term Debt|Short-Term Debt ACADIA Corp (ACAD)|Company Short-Term Debt Xenon Pharmaceuticals|Company Short-Term Indebtedness VKTX (vikingtherapeutics.com)|Company Short-Term Debts SUPN|CPRX - Short-Term Debt|Denali Therapeutics Inc - Company Current Liabilities|Company Short-Term Debts Harmony Corp HRMY|BHVN - Company Short-Term Debt|Company Short-Term Loans and Borrowings AMLX (amylyx.com)|Trevi Therapeutics, Inc. (TRVI) - Company Short-Term Debt|Short-Term Debt Praxis Precision Medicines Inc (PRAX)|AVXL (Anavex Corp) - Company Short-Term Debts|Company Current Liabilities CeriBell EEG (CBLL)|Company Short-Term Debt Prothena (PRTA)|ALEC (alector.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ANNX (Annexon)|Short-Term Debt Volume Omeros Corp (OMER)|NGNE - Company Short-Term Debt|ACIU (AC Immune Inc) - Company Short-Term Indebtedness|VYGR: Company Short-Term Debts|Short-Term Debt neumoratx.com (NMRA)|Company Current Liabilities SCLX|TVGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACOG|Company Short-Term Debt CGTX (cogrx.com)|Company Short-Term Debts IKT (Inhibikase Therapeutics)|Short-Term Debt Volume cassavasciences.com (SAVA)|ASRT - Company Short-Term Debt|Short-Term Debt Coya Therapeutics, Inc.|vistagen.com (VTGN) - Company Short-Term Debt|OVID - Short-Term Debt Volume|ABOS (Acumen Pharmaceuticals) - Company Short-Term Debts|Company Current Liabilities cervomed.com (CRVO)|Company Short-Term Debts ATHE|Short-Term Debt Volume clene.com|Company Short-Term Debts PEPG (PepGen)|jupiterneurosciences.com (JUNS) - Short-Term Debt|RLMD - Company Short-Term Debt|ANVS (annovisbio.com) - Company Short-Term Indebtedness|GRCE: Company Short-Term Debts|Company Current Liabilities Firefly Neuroscience, Inc.|KLTO (ANEW Medical) - Company Short-Term Debts|Short-Term Debt NeuroSense Therapeutics, Ltd. NRSN|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Short-Term Debt Volume metaviatx.com|Company Short-Term Debt NeurAxis NRXS|HSDT: Company Short-Term Indebtedness|Passage Bio Corp - Company Short-Term Debts|NEUP: Company Short-Term Debt|NERV: Company Short-Term Debts|ATHA - Short-Term Debt Volume|Company Current Liabilities ADXN|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Short-Term Indebtedness|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Short-Term Debt|ATXI: Company Current Liabilities|BCLI - Company Short-Term Debts|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Chromocell - Company Short-Term Loans and Borrowings|Company Short-Term Debt Eliem Therapeutics, Inc.|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Marinus Pharmaceuticals Inc - Company Short-Term Indebtedness|Company Short-Term Debts NKGN (NKGen)|NeuroBo Pharma (NRBO) - Short-Term Debt|SAGE: Company Current Liabilities|SNPX - Company Short-Term Debts|Trevena (TRVN) - Company Short-Term Debt|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Anew Medical, Inc.|Short-Term Debt Cerevel Corp CERE